Browse the preliminary programme and build a personalised schedule for the congress.

Displaying One Session

Clinical Focus
Moderators
  • G. J. Adema (Nijmegen, NL)
  • S. Goldberg (Jerusalem, IL)
Date
Mon, Apr 8, 2019
Time
10:30 - 12:00

201.1 - Immune alterations in solid tumours

Presenter:
  • W. H. Fridman (Paris, FR)
Learning Objectives:
1. To understand the role of immunity in normal physiology
2. To understand mechanisms of immune escape in cancer
3. To learn about prognosis immunity markers in cancer subtypes

201.2 - Immune checkpoint inhibitors - how do they work?

Presenter:
  • A. Digklia (Lausanne, CH)
Learning Objectives:
1. To learn about mechanisms of action for available immune checkpoint inhibitors
2. To learn about the added value of combination therapies in renal cell carcinomas
3. To better understand side effects of ICI

201.3 - Immune response: the role of the tumour

Presenter:
  • G. Malouf (Strasbourg, FR)
Learning Objectives:
1. To understand the crosstalk between genetic alterations in the tumours and immune alterations
2. To understand how to infer immune-cell infiltrate from transcriptomic data
3. To understand predictive tumour markers associated with response to immune checkpoints inhibitors

201.4 - Immune response: the role of the microenvironment

Presenter:
  • C. Ottensmeier (Southampton, GB)
Learning Objectives:
1. To understand role of TIL
2. To learn about the link between immunity and response to immune checkpoint inhibitors
3. To learn about future strategies for targeting immune microenvironment

201.5 - Mechanisms of priming immune response using local treatment

Presenter:
  • M. Ahmed (Boston, US)
Learning Objectives:
1. To understand the concept of priming
2. To learn about old strategies used for priming
3. To understand novel strategies for priming immune response